BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baldini C, Talarico R, Della Rossa A, Bombardieri S. Clinical manifestations and treatment of Churg-Strauss syndrome. Rheum Dis Clin North Am 2010;36:527-43. [PMID: 20688248 DOI: 10.1016/j.rdc.2010.05.003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Faverio P, Bonaiti G, Bini F, Vaghi A, Pesci A. Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy. Ther Clin Risk Manag 2018;14:2385-96. [PMID: 30573961 DOI: 10.2147/TCRM.S159949] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
2 Jaimes-Hernández J, Mendoza-Fuentes A, Meléndez-Mercado CI, Aranda-Pereira P. Chronic eosinophilic pneumonia: autoimmune phenomenon or immunoallergic disease? Case report and literature review. Reumatol Clin 2012;8:145-8. [PMID: 22196999 DOI: 10.1016/j.reuma.2011.09.005] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Kitamura N, Hamaguchi M, Nishihara M, Ikumi N, Sugiyama K, Nagasawa Y, Tsuzuki H, Yoshizawa S, Tanikawa Y, Oshima M, Asatani S, Kobayashi H, Takei M. The effects of mepolizumab on peripheral circulation and neurological symptoms in eosinophilic granulomatosis with polyangiitis (EGPA) patients. Allergology International 2021;70:148-9. [DOI: 10.1016/j.alit.2020.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Amini-Vaughan ZJ, Martinez-Moczygemba M, Huston DP. Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer. Curr Allergy Asthma Rep 2012;12:402-12. [PMID: 22875242 DOI: 10.1007/s11882-012-0290-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
5 Miloslavsky E, Unizony S. The Heart in Vasculitis. Rheumatic Disease Clinics of North America 2014;40:11-26. [DOI: 10.1016/j.rdc.2013.10.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
6 Ye L, Lu X, Xue J. Eosinophilic granulomatosis with polyangiitis complicated by cholecystitis: a case report and review of the literature. Clin Rheumatol 2016;35:259-63. [DOI: 10.1007/s10067-014-2521-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
7 Kim DS, Song JJ, Park Y, Lee S. Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis. Int J Rheum Dis 2017;20:1261-8. [DOI: 10.1111/1756-185x.13056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
8 Bitar AY, Thompson CD, Tan CW, Allem K, Khachatrian A, Weis PJ, Garg V, Srivastava A. Coronary artery vasospasm and cardiogenic shock as the initial presentation for eosinophilic granulomatosis with polyangiitis. J Cardiol Cases 2016;13:105-8. [PMID: 30546619 DOI: 10.1016/j.jccase.2015.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Abril A. Churg-strauss syndrome: an update. Curr Rheumatol Rep 2011;13:489-95. [PMID: 21863326 DOI: 10.1007/s11926-011-0205-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
10 Chen Y, Ding Y, Liu Z, Zhang H, Liu Z, Hu W. Long-term outcomes in antineutrophil cytoplasmic autoantibody-positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 Chinese patients. BMC Nephrol 2016;17:101. [PMID: 27461086 DOI: 10.1186/s12882-016-0319-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Nishihara M, Hamaguchi M, Ikumi N, Nishiwaki A, Sugiyama K, Nagasawa Y, Tsuzuki H, Yoshizawa S, Tanikawa Y, Asatani S, Kobayashi H, Takei M, Kitamura N. Successful early introduction of mepolizumab for peripheral neuropathy with a peripheral circulatory disorder in a patient with myeloperoxidase anti-neutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis. Mod Rheumatol Case Rep 2021;5:354-9. [PMID: 33970058 DOI: 10.1080/24725625.2021.1916159] [Reference Citation Analysis]
12 Ullah S, Ali M, Kyaw P, Nayeemuddin F, Sreedhar R, Gao J. P-ANCA negative eosinophilic granulomatosis with polyangiitis. Respir Med Case Rep 2019;27:100830. [PMID: 30989049 DOI: 10.1016/j.rmcr.2019.100830] [Reference Citation Analysis]
13 Schmidt J, Pulido JS, Matteson EL. Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Ophthalmol 2011;22:489-95. [PMID: 21918443 DOI: 10.1097/ICU.0b013e32834bdfe2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
14 Tombetti E, Mulè A, Tamanini S, Matteucci L, Negro E, Brucato A, Carnovale C. Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020. Curr Cardiol Rep 2020;22:59. [PMID: 32562029 DOI: 10.1007/s11886-020-01308-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
15 Ekeigwe NL, Adelowo O, Anaba EL, Olaosebikan H. Eosinophilic granulomatosis with polyangiitis in a Nigerian woman. BMJ Case Rep 2019;12:e228901. [PMID: 31217209 DOI: 10.1136/bcr-2018-228901] [Reference Citation Analysis]
16 Perumal B, Black EH, Levin F, Servat JJ. Non-infectious orbital vasculitides. Eye (Lond) 2012;26:630-9. [PMID: 22361845 DOI: 10.1038/eye.2012.28] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
17 Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G, Altissimi G, De Vincentiis M. Churg-Strauss syndrome. Autoimmun Rev 2015;14:341-8. [PMID: 25500434 DOI: 10.1016/j.autrev.2014.12.004] [Cited by in Crossref: 152] [Cited by in F6Publishing: 113] [Article Influence: 19.0] [Reference Citation Analysis]
18 Moore GH, Rootman DB. Orbital inflammatory disease management. Expert Review of Ophthalmology 2016;11:415-28. [DOI: 10.1080/17469899.2016.1233399] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Wang Z, Han L, Yu L. Effects of surgery and topical medication on eosinophilic granulomatosis with polyangiitis with otitis media and sinusitis: a case report. J Int Med Res 2020;48:300060520920049. [PMID: 32345078 DOI: 10.1177/0300060520920049] [Reference Citation Analysis]
20 Abonia JP, Putnam PE. Mepolizumab in eosinophilic disorders. Expert Rev Clin Immunol 2011;7:411-7. [PMID: 21790283 DOI: 10.1586/eci.11.27] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
21 O'Meara P, Borici-Mazi R, Morton AR, Ellis AK. DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin. Allergy Asthma Clin Immunol 2011;7:16. [PMID: 21968185 DOI: 10.1186/1710-1492-7-16] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
22 Parent ME, Larue S, Ellezam B. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis. BMC Musculoskelet Disord 2014;15:388. [PMID: 25414144 DOI: 10.1186/1471-2474-15-388] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
23 Pandita KK, Bhat KJ, Razdan S, Kudyar RP. "Peripheral neuropathy crippling bronchial asthma": two rare case reports of churg-strauss syndrome. Case Rep Pulmonol 2014;2014:673906. [PMID: 25580342 DOI: 10.1155/2014/673906] [Reference Citation Analysis]
24 Pecoraro A, Crescenzi L, Carucci L, Genovese A, Spadaro G. Heart failure not responsive to standard immunosuppressive therapy is successfully treated with high dose intravenous immunoglobulin therapy in a patient with Eosinophilic Granulomatosis with Polyangiitis (EGPA). Int Immunopharmacol 2017;45:13-5. [PMID: 28152445 DOI: 10.1016/j.intimp.2017.01.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sussex J, Rollet P, Garau M, Schmitt C, Kent A, Hutchings A. Multi-Criteria Decision Analysis to Value Orphan Medicines. SSRN Journal. [DOI: 10.2139/ssrn.2631463] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Matsuno O, Minamoto S. Flare of eosinophilic granulomatosis with polyangiitis related to pregnancy: Case report and review of the literature. Respir Med Case Rep 2019;26:23-6. [PMID: 30456168 DOI: 10.1016/j.rmcr.2018.10.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Vázquez-Triñanes C, Sopeña B, González-González L, Díaz R, Rivera A, Freire M, Martínez-Vázquez C. Synovial fluid eosinophilia: a case series with a long follow-up and literature review. Rheumatology (Oxford) 2013;52:346-51. [PMID: 23041597 DOI: 10.1093/rheumatology/kes236] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
28 Yılmaz İ, Türk M, Bahçecioğlu SN. Classification of eosinophilic granulomatosis with polyangiitis phenotypes and treatment based on phenotypes. Autoimmun Rev 2017;16:992-3. [PMID: 28711579 DOI: 10.1016/j.autrev.2017.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
29 Kim MY, Sohn KH, Song WJ, Park HW, Cho SH, Min KU, Kang HR. Clinical features and prognostic factors of Churg-Strauss syndrome. Korean J Intern Med 2014;29:85-95. [PMID: 24574837 DOI: 10.3904/kjim.2014.29.1.85] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
30 Detoraki A, Tremante E, Poto R, Morelli E, Quaremba G, Granata F, Romano A, Mormile I, Rossi FW, de Paulis A, Spadaro G. Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series. Respir Res 2021;22:185. [PMID: 34162391 DOI: 10.1186/s12931-021-01775-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Burtson KM, Bishop J. Prevasculitic Eosinophilic Granulomatosis With Polyangiitis. Cureus 2021;13:e14649. [PMID: 34055509 DOI: 10.7759/cureus.14649] [Reference Citation Analysis]
32 Aguilar PR, Walgama ES, Ryan MW. Other asthma considerations. Otolaryngol Clin North Am 2014;47:147-60. [PMID: 24286688 DOI: 10.1016/j.otc.2013.08.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
33 Santos YA, Silva BR, Lira PN, Vaz LC, Mafort TT, Bruno LP, Lopes AJ. Eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome) as a differential diagnosis of hypereosinophilic syndromes. Respir Med Case Rep 2017;21:1-6. [PMID: 28337408 DOI: 10.1016/j.rmcr.2017.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
34 Wechsler ME, Akuthota P, Jayne D, Khoury P, Klion A, Langford CA, Merkel PA, Moosig F, Specks U, Cid MC, Luqmani R, Brown J, Mallett S, Philipson R, Yancey SW, Steinfeld J, Weller PF, Gleich GJ; EGPA Mepolizumab Study Team. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med. 2017;376:1921-1932. [PMID: 28514601 DOI: 10.1056/nejmoa1702079] [Cited by in Crossref: 345] [Cited by in F6Publishing: 113] [Article Influence: 69.0] [Reference Citation Analysis]
35 Rhee RL, Holweg CTJ, Wong K, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland LW, Pagnoux C, Seo P, Specks U, Sreih AG, Ytterberg SR, Merkel PA; Vasculitis Clinical Research Consortium. Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis. PLoS One 2018;13:e0205768. [PMID: 30308057 DOI: 10.1371/journal.pone.0205768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Hurrell JM, Genta RM, Melton SD. Histopathologic diagnosis of eosinophilic conditions in the gastrointestinal tract. Adv Anat Pathol. 2011;18:335-348. [PMID: 21841404 DOI: 10.1097/pap.0b013e318229bfe2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
37 Takayasu V, Felipe-Silva A. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) syndrome and pulmonary thromboembolism: an overlooked concomitance. Autops Case Rep 2013;3:11-9. [PMID: 31528603 DOI: 10.4322/acr.2013.013] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Narula N, Narula T, Derbes S, Espinoza LR. Churg-Strauss angiitis. Am J Med Sci 2014;348:522-7. [PMID: 24172234 DOI: 10.1097/MAJ.0b013e31829f8306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Tamechika SY, Isogai S, Maeda S, Naniwa T, Niimi A. Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis by Additional Mepolizumab. Case Rep Rheumatol 2021;2021:5561762. [PMID: 33859858 DOI: 10.1155/2021/5561762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Fulkerson PC, Rothenberg ME. Eosinophil Development, Disease Involvement, and Therapeutic Suppression. Adv Immunol 2018;138:1-34. [PMID: 29731004 DOI: 10.1016/bs.ai.2018.03.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
41 Ungprasert P, Srivali N, Cheungpasitporn W, Schaeffer CS. Is it acute coronary syndrome or Churg-Strauss syndrome? Am J Emerg Med 2013;31:270.e5-8. [PMID: 22809775 DOI: 10.1016/j.ajem.2012.05.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
42 Mroz RM, Korniluk M, Swidzinska E, Chyczewska E. Churg-Strauss syndrome: a case report. Eur J Med Res 2010;15 Suppl 2:92-4. [PMID: 21147630 DOI: 10.1186/2047-783x-15-s2-92] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Aguirre-Valencia D, Posso-Osorio I, Bravo JC, Bonilla-Abadía F, Tobón GJ, Cañas CA. Sequential rituximab and omalizumab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Clin Rheumatol 2017;36:2159-62. [PMID: 28762062 DOI: 10.1007/s10067-017-3780-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]